Showing results (101-110 of 9,088) with videos related to
Sort By:
Pageof 909
Infection and Immunity|February 1, 1994
Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formationT Nishihara, Y Ohsaki, N Ueda, et al.Stem Cells (Dayton, Ohio)|August 1, 1995
An in vivo model of human multiple myeloma bone diseaseM Alsina, B F Boyce, G R Mundy, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1993
The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitroT A Guise, T Yoneda, A J Yates, et al.Calcified Tissue International|March 1, 1997
Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblastsD Chen, M A Harris, G Rossini, et al.The Journal of Cell Biology|June 25, 1998
Cadherin-6 mediates the heterotypic interactions between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiationG Mbalaviele, R Nishimura, A Myoi, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1991
Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclastsA J Yates, R O Oreffo, K Mayor, et al.The American Journal of Medicine|October 1, 1978
Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapyG R Mundy, M E Rick, R Turcotte, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal miceM Sabatini, B Boyce, T Aufdemorte, et al.Clinical Pharmacology and Therapeutics|April 1, 1976
Sodium salicylamide: relative bioavailability and subjective effectsL Fleckenstein, G R Mundy, R A Horovitz, et al.Endocrinology|August 1, 1991
Differentiation of HL-60 cells into cells with the osteoclast phenotypeT Yoneda, M M Alsina, J L Garcia, et al.Pageof 909